These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8434758)

  • 1. Infusion charts for inotropes.
    Allen JG
    Anaesthesia; 1993 Jan; 48(1):78. PubMed ID: 8434758
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post hoc analysis of the glutamics-trial: intravenous glutamate infusion and use of inotropic drugs after cabg.
    Vidlund M; Tajik B; Håkanson E; Friberg Ö; Holm J; Vanky F; Svedjeholm R
    BMC Anesthesiol; 2016 Aug; 16(1):54. PubMed ID: 27484576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery system.
    Starr AF; Alexander JC
    W V Med J; 1984 May; 80(5):87-8. PubMed ID: 6588673
    [No Abstract]   [Full Text] [Related]  

  • 5. Infusion therapy in severe heart failure. A reappraisal.
    Campana C; Scelsi L; Serio A
    Ital Heart J; 2003 May; 4 Suppl 2():15S-21S. PubMed ID: 14635365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent infusion of inotropes in the outpatient setting: one-year post treatment analysis.
    López-Candales A; Carron C; Graham S; Schwartz J
    P R Health Sci J; 2000 Jun; 19(2):107-14. PubMed ID: 10909705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study.
    López-Candales A; Vora T; Gibbons W; Carron C; Simmons P; Schwartz J
    J Med; 2002; 33(1-4):129-46. PubMed ID: 12939113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.
    Nishi K; Sato Y; Miyamoto T; Toma M; Taniguchi R; Fukuhara R; Saijo S; Fujiwara H; Takatsu Y
    J Cardiol; 2012 May; 59(3):366-73. PubMed ID: 22365946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low serum thyrotropin associated with intravenous dopamine infusion].
    Calvo Romero JM; Lima Rodríguez EM
    Med Clin (Barc); 2004 Jul; 123(5):199. PubMed ID: 15274802
    [No Abstract]   [Full Text] [Related]  

  • 10. Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience.
    Pacher R; Stanek B
    Eur J Heart Fail; 1999 Aug; 1(3):263-8. PubMed ID: 10935673
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of the changeover of inotrope infusions in children.
    Arino M; Barrington JP; Morrison AL; Gillies D
    Intensive Crit Care Nurs; 2004 Oct; 20(5):275-80. PubMed ID: 15450616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular agents in therapy of premature and newborn infants].
    Gajdos S
    Kinderkrankenschwester; 2009 Jan; 28(1):14-9. PubMed ID: 19235330
    [No Abstract]   [Full Text] [Related]  

  • 13. Overdilution of drug preparations.
    Belaro AP
    Am J Crit Care; 2000 Sep; 9(5):367. PubMed ID: 10976362
    [No Abstract]   [Full Text] [Related]  

  • 14. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quick change versus double pump while changing the infusion of inotropes: an experimental study.
    de Barbieri I; Frigo AC; Zampieron A
    Nurs Crit Care; 2009; 14(4):200-6. PubMed ID: 19531038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience.
    Malotte K; Saguros A; Groninger H
    J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative isoproterenol infusion in a patient with Brugada syndrome.
    Lin YC; Chen CC; Yang CC
    Can J Anaesth; 2017 May; 64(5):552-553. PubMed ID: 28150159
    [No Abstract]   [Full Text] [Related]  

  • 18. To infuse or not?
    Habet KJ
    Chest; 2004 Apr; 125(4):1182-3. PubMed ID: 15078718
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical considerations in the administration of intravenous vasoactive drugs in the critical care setting. Part II--how safe is our practice?
    Morrice A; Jackson E; Farnell S
    Intensive Crit Care Nurs; 2004 Aug; 20(4):183-9. PubMed ID: 15288871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
    Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
    Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.